Navigation Links
Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Reduction in Clinical Events in Patients for 18 Months Compared with Placebo
Date:5/23/2011

th period strongly support the continued development of MYDICAR for a Phase 3 study and commercialization," said Roger Hajjar, M.D., Director, Cardiovascular Research Center, Mount Sinai School of Medicine, NY, and  co-founder of Celladon. "The clinical deterioration seen in the placebo patients receiving ongoing optimal standard therapy emphasizes the tremendous unmet medical need in people with advanced heart failure. Based on these results we are encouraged that MYDICAR can fill this need."  

The CUPID Trial

The CUPID trial (Calcium Up-regulation by Percutaneous administration of gene therapy In cardiac Disease) is a randomized, double-blind, placebo-controlled study to assess the efficacy and safety of MYDICAR®, a genetically targeted enzyme replacement therapy for advanced heart failure. Enrolled patients had severe forms of the disease defined by New York Heart Association Class III or IV heart failure, significantly impaired pumping function of their hearts (ejection fraction ≤ 35 percent), and less than half the normal ability to transport and utilize oxygen during exercise testing (VO2max ≤20 mL/kg/min). The CUPID trial ClinicalTrials.gov Identifier is NCT00454818.

Primary outcome measures included safety, worsening of heart failure leading to hospitalization, frequency of and time to cardiac transplantation or LVAD implantation, changes in patients' ability to exercise, echocardiographic assessments, a blood test for NT-proBNP, and symptoms of heart failure.

About MYDICAR®

MYDICAR® is a genetically targeted enzyme replacement therapy intended to restore levels of SERCA2a, a regulator of calcium cycling and contractility. SERCA2a levels decline in all forms of late-stage heart failure resulting in deficient heart function. With MYDICAR®, the SERCA2a gene is delivered using a recombinant adeno-associated virus (AAV) as the vec
'/>"/>

SOURCE Celladon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
2. Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy
3. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
4. Gumz to Retire as President and CEO of Olympus Corporation of the Americas
5. Medication Delivery Innovator Baxa Corporation Offers Best Practices for Administering Over-the-Counter Liquid Medicine to Babies and Toddlers
6. Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA
7. TechPrecision Corporation Receives $1.6 Million in New Orders from Existing Customers
8. SenSage Named Cerner Corporations Accelerate Partner of the Year
9. Boston Scientific Announces Favorable Jury Verdict Against Cordis Corporation in Stent Patent Litigation
10. Henry Schein Ranks #317 in 2011 Fortune 500 Ranking of Americas Largest Corporations
11. Omeros Corporation Reports First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... -- New high priced hepatitis C drugs will increase ... $2.9 to $5.8 billion next year, according to a ... by the Pharmaceutical Care Management Association (PCMA). Milliman projects ... much as 8.6 percent in 2015 as a result ... The study finds that the majority of ...
(Date:7/29/2014)... Conn. , July 29, 2014 Numotion,s Board ... Mike Swinford will be the company,s new Chief ... highly successful 22-year career at GE where he worked primarily ... in annual revenue to over $5 billion. His most recent ... Services. "I am thrilled to join Numotion," ...
(Date:7/29/2014)... 2014  Roche (SIX: RO, ROG; OTCQX: RHHBY) launched ... (AACC) 2014 Clinical Lab Expo today by unveiling two ... Roche is partnering with customers to redefine the value ... every day that they,re looking for a partner to ... labs and offices," said Jack Phillips , president ...
Breaking Medicine Technology:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Numotion Names Mike Swinford CEO 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4
... Calif., June 2, 2011 Clovis Oncology, Inc. and ... they have entered into an agreement to develop an ... companion diagnostic test. The goal is to identify activating ... non-small cell lung cancer (NSCLC), including the EGFR T790M ...
... /PRNewswire-iReach/ -- The Institute for ... of gluten-free food supplements and herbs.The Institute for ... for integrative rheumatology—has launched GLUTEN-FREE REMEDIES™, a line ... a new standard of quality. Selected for the ...
Cached Medicine Technology:Roche and Clovis Oncology to Co-Develop EGFR Companion Diagnostic 2Roche and Clovis Oncology to Co-Develop EGFR Companion Diagnostic 3The Institute for Specialized Medicine Launches GLUTEN-FREE REMEDIES, a New Line of Gluten-free Food Supplements and Herbs. 2
(Date:7/30/2014)... The San Diego personal injury lawyers of ... that they are now offering free case reviews for individuals ... exposure. , “Symptoms of asbestos exposure can take years to ... plus years ago may just now be suffering from the ... of Melinda J. Helbock A.P.C. “We want people to know ...
(Date:7/29/2014)... VisitandCare.com today announced that ... to the company’s exclusive network to help couples struggling ... efforts — as top fertility clinics in Spain, Switzerland, ... state-of-the-art, and successful IVF treatments. , The exclusive selection ... study by professionals at VisitandCare.com. The goal is to ...
(Date:7/29/2014)... 2014 1Heart Caregiver Services’ advocacy ... focus on Brain Fitness Education brings great acceptance ... Fitness Program Director Tee Barr delivered an exceptional ... unit and the Assisted Living section of Aegis ... Director Christy Rozsa and Aegis Life Neighborhood Director ...
(Date:7/29/2014)... chemical alteration in a single human gene linked to ... give doctors a simple blood test to reliably predict ... described online in The American Journal of Psychiatry ... the function of the brain,s response to stress hormones ... be an unremarkable reaction to the strain of everyday ...
(Date:7/29/2014)... Diabetes is a common condition diagnosed in ... levels are increased, while the production of insulin is decreased. ... and which is needed by the body to regulate blood ... be very dangerous, as there are numerous complications that can ... this disorder and read a complex review of Matt Traverso's ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Offers Case Evaluations for Possible Asbestos Claims 2Health News:Top European Fertility Clinics Join VisitandCare.com 2Health News:Top European Fertility Clinics Join VisitandCare.com 3Health News:Top European Fertility Clinics Join VisitandCare.com 4Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 3Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 4Health News:A blood test for suicide? 2Health News:A blood test for suicide? 3Health News:Reverse Your Diabetes Today Review Exposes Matt Traverso’s New eBook 2
... Looking for a unique, customized gift,for the animal lover ... Morris Animal Foundation (MAF) that benefits a favorite animal,-- dog, ... special gift for,anyone on your list. Many people who make ... notation in their holiday cards. A donation can be a,wonderful ...
... the body , , TUESDAY, Nov. 11 (HealthDay News) -- ... of high blood pressure in women who currently have ... new study by U.S. researchers who analyzed data from ... Lipoprotein particles carry cholesterol and triglycerides throughout the body. ...
... Chief Marketing,Executive at Online Buddies Inc., the parent ... of the Centers for Disease Control and Prevention,(CDC) ... as the site,s first Senior,Public Health Strategist. MANHUNT, ... 2,000,000 members worldwide, is the first social networking,site ...
... PRAIRIE, Minn., Nov. 11 Pam Kreager, ... Prairie, Minnesota-based Long Term,Care Group, Inc. (LTCG), ... Term Care,International Forum (LTCIF). The Long Term ... organization whose purpose is to promote,efficiency, effectiveness ...
... press release is available in French . ... created a new protein patterning technique that,s enabled them ... of a masterpiece painting. According to a new study ... from Universit de Montral, the Maisonneuve-Rosemont Hospital Research Centre, ...
... at the Yerkes National Primate Research Center, Emory University, ... and generation of several types of neural cells. Findings ... the journal Stem Cells , suggest dental pulp ... and regenerative medicine, particularly therapies associated with the central ...
Cached Medicine News:Health News:Unique Holiday Gift for Animal Lovers: A Donation to Fund Animal Health Research; Pick a Favorite Animal - Dog, Cat, Horse, All Species of Wildlife 2Health News:Lipoprotein Levels May Predict Women's Hypertension Risk 2Health News:MANHUNT Leads Fight Against Spread of Sexually Transmitted Infections with Launch of MANHUNT Cares; Hires Senior Public Health Strategist from CDC 2Health News:Long Term Care International Forum names LTCG's Pam Kreager as President 2Health News:New laser method reproduces art masterworks to protein patterns 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: